Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Hemocomponent therapy of central involution chorioretinal dystrophy]

A I Mukha, V S Lysenko, V V Galileeva

    Vestnik Oftalmologii
    |May 19, 1998
    PubMed
    Summary

    Activated autoplasma therapy improved vision in patients with central chorioretinal dystrophy. This hemocomponent treatment promoted resorption of hemorrhages and exudations, enhancing visual acuity in most treated eyes.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    [Safety, tolerability, and pharmacokinetics of verenafusp alfa in healthy volunteers: results of an open-label multicohort phase I study].

    Terapevticheskii arkhiv·2026
    Same author

    [Results of a prospective observational study of imiglucerase biosimilar in adults with type I Gaucher disease].

    Terapevticheskii arkhiv·2025
    Same author

    [Results of phase Ib open multicenter clinical trial of the safety, pharmacokinetics and pharmacodynamics of first biosimilar of eculizumab in untreated patients with paroxysmal nocturnal hemoglobinuria during induction of therapy].

    Terapevticheskii arkhiv·2020
    Same author

    Impact of defects on photoexcited carrier relaxation dynamics in GeSn thin films.

    Journal of physics. Condensed matter : an Institute of Physics journal·2020
    Same author

    Formation and Luminescent Properties of Al<sub>2</sub>O<sub>3</sub>:SiOC Nanocomposites on the Base of Alumina Nanoparticles Modified by Phenyltrimethoxysilane.

    Nanoscale research letters·2017
    Same author

    Experimental Modeling of Proliferative Vitreoretinopathy. An Experimental Morphological Study.

    Bulletin of experimental biology and medicine·2015

    Area of Science:

    • Ophthalmology
    • Regenerative Medicine

    Background:

    • Central chorioretinal dystrophy presents challenges in vision restoration.
    • Hemorrhages and exudations in the fundus oculi can significantly impair vision.

    Purpose of the Study:

    • To evaluate the efficacy of activated autoplasma therapy for central chorioretinal dystrophy.
    • To assess the resorptive and visual acuity outcomes of this hemocomponent therapy.

    Main Methods:

    • Hemocomponent therapy utilizing activated autoplasma was administered to 181 patients (347 eyes).
    • The therapy's effect on resorption of fundus hemorrhages and exudations was observed.

    Main Results:

    • Activated autoplasma demonstrated a marked resorptive effect, clearing hemorrhages and exudations.

    Related Experiment Videos

  • Vision acuity improved in 75% of the treated eyes.
  • The average improvement in vision acuity was 0.2 diopters.

    • Conclusions:

    • Activated autoplasma therapy is an effective hemocomponent treatment for central chorioretinal dystrophy.
    • The therapy promotes significant resorption of ocular hemorrhages and exudations.
    • This treatment leads to measurable improvements in visual acuity.